Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

SnET2 photodynamic therapy stabilizes visual acuity in subfoveal choroidal neovascularization

May 11, 1999

Ocufit SR provides sustained release of diclofenac into the sclera

May 11, 1999

AGN-192024 is more effective than timolol in lowering IOP in patients with glaucoma

May 11, 1999

InSite Vision signs agreement with U. of California for glaucoma gene rights

May 4, 1999

Allergen patents new thromboxane receptor ligands with particular utility in ocular hypertension

May 3, 1999

Alcon to continue Lu-Tex development

April 27, 1999

Steroidogenesis inhibitor tested in mouse model of hereditary blindness

April 15, 1999

Eye implant receives FDA approval for correcting mild myopia

April 13, 1999

PhotoVision in-licenses novel technology for development of AMD treatment

April 7, 1999

Xalatan approved in Japan for glaucoma and ocular hypertension

March 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....